Rardin Matthew J, Wiley Sandra E, Naviaux Robert K, Murphy Anne N, Dixon Jack E
Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.
Anal Biochem. 2009 Jun 15;389(2):157-64. doi: 10.1016/j.ab.2009.03.040. Epub 2009 Mar 31.
The pyruvate dehydrogenase multienzyme complex (PDC) is a key regulatory point in cellular metabolism linking glycolysis to the citric acid cycle and lipogenesis. Reversible phosphorylation of the pyruvate dehydrogenase enzyme is a critical regulatory mechanism and an important point for monitoring metabolic activity. To directly determine the regulation of the PDC by phosphorylation, we developed a complete set of phospho-antibodies against the three known phosphorylation sites on the E1 alpha subunit of pyruvate dehydrogenase (PDHE1alpha). We demonstrate phospho-site specificity of each antibody in a variety of cultured cells and tissue extracts. In addition, we show sensitivity of these antibodies to PDH activity using the pyruvate dehydrogenase kinase-specific inhibitor dichloroacetate. We go on to use these antibodies to assess PDH phosphorylation in a patient suffering from Leigh's syndrome. Finally, we observe changes in individual phosphorylation states following a small molecule screen, demonstrating that these reagents should be useful for monitoring phosphorylation of PDHE1alpha and, therefore, overall metabolism in the disease state as well as in response to a myriad of physiological and pharmacological stimuli.
丙酮酸脱氢酶多酶复合体(PDC)是细胞代谢中的一个关键调控点,它将糖酵解与柠檬酸循环及脂肪生成联系起来。丙酮酸脱氢酶的可逆磷酸化是一种关键的调控机制,也是监测代谢活性的一个重要切入点。为了直接确定磷酸化对PDC的调控作用,我们针对丙酮酸脱氢酶E1α亚基(PDHE1α)上三个已知的磷酸化位点开发了一整套磷酸化抗体。我们在多种培养细胞和组织提取物中证明了每种抗体的磷酸化位点特异性。此外,我们使用丙酮酸脱氢酶激酶特异性抑制剂二氯乙酸展示了这些抗体对PDH活性的敏感性。我们接着使用这些抗体评估一名患有 Leigh 综合征患者的PDH磷酸化情况。最后,我们在小分子筛选后观察到各个磷酸化状态的变化,表明这些试剂对于监测PDHE1α的磷酸化以及疾病状态下的整体代谢,以及对众多生理和药理刺激的反应应该是有用的。